Virus Identified as Cause of Multiple Sclerosis
A new study shows the Epstein-Barr virus (EBV) is essential for the development of multiple sclerosis (MS).
FDA Approves Argenx’s Vyvgart to Treat MG
The U.S. Food and Drug Administration (FDA) has approved Vyvgart (efgartigi-mod) to treat generalized myasthenia gravis (gMG) in adults who test positive for the anti-acetylcholine receptor (AChR) antibody.
Two Major Changes in Medicare in 2022
The COVID-19 pandemic highlighted gaps the healthcare system. Two improvements to Medicare in 2022 seek to give people greater access to telehealth and other care delivery options.
Researchers at Emory University Awarded Grant to Pursue a Cure for HIV
An Emory University-led research collaboration has been awarded a five-year $23.8 million grant from the National Institutes of Health (NIH) to fast-track research to cure HIV infection or put it in permanent remission.
HHS Study Shows 63-Fold Increase in Medicare Telehealth Utilization During the Pandemic
A report from the U.S. Department of Health and Human Services (HHS) has found that considerable increases in the use of telehealth helped maintain some healthcare access during the COVID- 19 pandemic,
FDA Approves Novartis’ Cosentyx to Treat Arthritis in Children and Adolescents
Novartis has received U.S. Food and Drug Administration (FDA) approval for its Cosentyx (secukinumab) to treat children and adolescents with enthesitis-related arthritis and psoriatic arthritis.
Many Clinically Stable CIDP Patients Can Safely Stop IVIG Maintenance Treatment
While intravenous immune globulin (IVIG) therapy is efficacious for patients with chronic inflammatory demyelinating polyneuropathy (CIDP), the lack of biomarkers for disease activity makes the need for ongoing treatment difficult to assess.
Addition of Eltrombopag Improves Efficacy of Standard Therapy for Aplastic Anemia
Eltrombopay found to improve therapy for aplastic anemia.
Experimental Vaccine Developed to Prevent Rheumatoid Arthritis
Researchers at the University of Toledo have developed an experimental vaccine to prevent rheumatoid arthritis, one of the most common autoimmune disorders
COVID-19 Infection Alters Pregnant Mothers’ and Their Newborns’ Immunity
Investigators found COVID-19 infection altered the mothers’ immunity at delivery, and gestational COVID-19 exposure alters the immunity of newborns.